Publications

Link to my profile on Google Scholar

2019

  • Quandt JA, Becquart P, Kamma E, Hallenbeck J. Mucosal administration of E-selectin limits disability in models of multiple sclerosis. Frontiers in Molecular Neuroscience In Press
  • Muir F, Samdi-Barahmi Z, Moore GEW, Quandt JA. Expression of CD1d by astrocytes corresponds with relative activity in MS lesions. Brain Pathology.  May 3. doi: 10.1111/bpa.12733. [Epub ahead of print]
  • Vilarino-Guell, C., Zimprich, A., Martinelli-Boneschi, F., Herculano, B., Wang, Z., Matesanz, F., Urcelay, E., Vandenbroeck, K., Leyva, L., Gris, D., Massaad, C., Quandt, J.A., Traboulsee, A.L., Encarnacion, M., Bernales, C.Q., Follett, J., Yee, I.M., Criscuoli, M.G., Deutschländer, A., Reinthaler, E.M., Zrzavy, T., Mascia, E., Zauli, A., Esposito, F., Alcina, A., Izquierdo, G., Espino- Paisán, L., Mena, J., Antigüedad, A., Urbaneja-Romero, P., Ortega-Pinazo, J., Song, W. & Sadovnick, A.D. Exome sequencing in multiple sclerosis families id 1 entifies 12 candidate genes and nominates biological pathways for the genesis of disease.  PLOS Genetics.  2019 doi.org/10.1371/ journal.pgen.1008180

2018

  • Rahim T, Becquart P, Baeva M-E, Quandt JA. Expression of the neuroprotective protein aryl hydrocarbon receptor nuclear translocator 2 correlates with neuronal stress and disability in models of multiple sclerosis. J Neuroinflammation 2018 Sep 19;15(1):270. doi: 10.1186/s12974-018-1290-6
  • Waubant E, Amezcua L, Sicotte N, Hellwig K, Krupp L, Weinstock-Guttman B, Yeh A, Lucas RM, Longbrake EE, Yadav V, Rensel M, Mar S, Hersh C, Block V, Zipp F, Han MH, Spain R, Kelland EE, Charvet L, Dimitri D, Papeix C, Cross AH, Inglese M, Pia Amato M, Airas L, Leray E, Pia Sormani M, Van der Walt A, Vukusic S, Castillo-Trivino T, Tenembaum S, Ciccarelli O, Bommarito G, Petracca M, Gulowsen Celius E, Carson MJ, Hua LH, Van der Mei I, Lubetzki C, Jokubaitis V, Trojano M, Voskuhl R, Tintore M, Harbo H, Asgari N, Piccio L, Burton JM, Tremlett H, Goldman MD, Michel L, Zhang Y, Bove R, Quandt JA, Costello F, Ionete C, Lebrun-Frenay C, Pakpoor J, Bevan C, Morrow SA, Waldman AT, Oh J, Jacobs D, Palace J, Marrie RA, Tiwari-Woodruff SK, Metz LM, Cortese R, Chitnis T, Benson L, Benveniste E, Conway J, Sand IK, Murphy JO, Kita M, Riley C, Goverman JM, Langer-Gould AM, Azevedo CJ, Berrios Morales J, Barcellos LF, Crabtree E, Plummer P, Shirani A, Whartenby K, Brilot-Turville F, Kingwell E, Coyle P, Mowry E, Zabad R, Bielekova B, Monson N, Laule C, Burnett M, Schreiner T, Grinspan J, Dobson R, Akassoglou K, Graves J, Gray O, Smyth P, Havrdova EK, Preiningerova JL, Banwell B, Makhani N, Lucchinetti C, Arrambide G, Maillart E, Macklin W, and Gilmore W on behalf of the International Women in MS. Gender Inequities in the Multiple Sclerosis Community: A Call for Action. Ann Neurol. 2018 Nov 2. doi: 10.1002/ana.25359.
  • Yong H, Chartier G, Quandt JA. Modulating inflammation and neuroprotection in multiple sclerosis. Review.  J Neurosci Res. 2018 Jun;96(6):927-950. doi: 10.1002/jnr.24090 view paper here

2017

  • Yu A, Neil S, Quandt JA. High yield primary microglial cultures using granulocyte macrophage colony stimulating factor from embryonic murine cerebral cortical tissue. J Neuroimmunol. 2017 Jun 15;307:53-62  view paper here
  • Neil S, Huh J, Baronas V, Li X, McFarland HF, Cherukuri M, Mitchell JBM, Quandt JA. Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models. Brain Behav Immun. 2017 May; 62:332-343. view paper here

2016 and earlier

  • Alkabie S, Basivireddy J, Zhou L, Roskams J, Rieckmann P, Quandt JA. SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties. J Neuroinflammation. 2016 Aug 31;13(1):225 view paper here
  • Yuen TF, Johnson K, Zhao C, Quandt JA, McFarland HF, Franklin RBJ, ffrench-Constant C. Identification of endothelin-2 as an inflammatory factor that promotes CNS remyelination in the rodent. Brain 2013 Apr; 136(Pt 4):1035-47 
  • Quandt JA, Huh J, Baig M, Yao K, Ito N, Bryant M, Kawamura K, Pinilla C, McFarland HF, Martin R, Ito K. Humanized models support the etiologic role of DRB5*0101 in multiple sclerosis. J Immunol. 2012 Sept; 89;2897-2908.
  • Li X, Johnson K, Bryant M, Elkahloun AG, Amar M, Remaley AT, De Silva R, Hallenbeck JM, Quandt JA. Intranasal Delivery of E-selectin Reduces Atherosclerosis in ApoE-/-Mice. PLOS one. 2011 6(6):e20620
  • Kawamura K, Yao K, Quandt JA, Huh J, Baig M, Quigley L, Ito N, Necker A, McFarland HF, Muraro PA, Martin R, Ito K. Different development of myelin basic protein agonist- and antagonist-specific human TCR transgenic T cells in the thymus and periphery. J Immunol. 2008 Oct 15;181(8):5462-72.
  • Cassiani-Ingoni R, Muraro PA, Magnus T, Reichert-Scrivner S, Schmidt J, Huh J, Quandt JA, Bratincsak A, Shahar T, Eusebi F, Sherman LS, Mattson MP, Martin R, Rao MS. Disease progression after bone marrow transplantation in a model of multiple sclerosis is associated with chronic microglial and glial progenitor response. J Neuropathol Exp Neurol. 2007 Jul;66(7):637-49.
  • Gelderblom H, Londoño D, Bai Y, Cabral ES, Quandt J, Hornung R, Martin R, Marques A, Cadavid D. High production of CXCL13 in blood and brain during persistent infection with the relapsing fever spirochete Borrelia turicatae. J Neuropathol Exp Neurol. 2007 Mar;66(3):208-17.
  • Gelderblom H, Schmidt J, Londoño D, Bai Y, Quandt J, Hornung R, Marques A, Martin R, Cadavid D. Role of interleukin 10 during persistent infection with the relapsing fever Spirochete Borrelia turicatae. Am J Pathol. 2007 Jan;170(1):251-62.
  • Lünemann JD, Gelderblom H, Sospedra M, Quandt JA, Pinilla C, Marques A, Martin R. Cerebrospinal fluid-infiltrating CD4+ T cells recognize Borrelia burgdorferi lysine-enriched protein domains and central nervous system autoantigens in early lyme encephalitis. Infect Immun. 2007 Jan;75(1):243-51.
  • Li Y, Huang Y, Lue J, Quandt JA, Martin R, Mariuzza RA. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 2005 Sep 7;24(17):2968-79.
  • Quandt JA, Baig M, Yao K, Kawamura K, Huh J, Ludwin SK, Bian HJ, Bryant M, Quigley L, Nagy ZA, McFarland HF, Muraro PA, Martin R, Ito K. Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice. J Exp Med. 2004 Jul 19;200(2):223-34.
  • Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol. 2004 May;55(5):654-9.
  • Shukaliak-Quandt J, Borras E, Prat E, Gelderblom H, Houghten RA, Kashani A, Pinilla C, Stuerzebecher CS, Martin R. Peptidic complex mixtures as therapeutic agents in CNS autoimmunity. Mol Immunol. 2004 Feb;40(14-15):1075-87.
  • Shukaliak-Quandt JA, Dorovini-Zis K, Wu V, Prameya R. The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4+ T cell subsets to human brain endothelial cells (HBMEC) in vitro. J Neuropath Exp Neurol 2004 63:350-362.